ANAVEX LIFE SCIENCES CORP. Public Float
ANAVEX LIFE SCIENCES CORP. (AVXL) had Public Float of $708.00 million as of 2025-03-31, per its 10-K/A filed 2026-08-28.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-08-28
- 2025-03-31: Entity Public Float $708.00M.
- 2024-03-31: Entity Public Float $412.00M.
- 2023-03-31: Entity Public Float $667.00M.
- 2022-03-31: Entity Public Float $921.00M.
| Period end | Entity Public Float |
|---|---|
| 2025-03-31 | $708.00M 10-K/A · filed 2026-08-28 |
| 2024-03-31 | $412.00M 10-K · filed 2024-12-23 |
| 2023-03-31 | $667.00M 10-K · filed 2023-11-27 |
| 2022-03-31 | $921.00M 10-K · filed 2022-11-28 |
| 2021-03-31 | $1.01B 10-K · filed 2021-11-24 |
| 2020-03-31 | $177.40M 10-K · filed 2020-12-28 |
| 2019-03-31 | $139.77M 10-K · filed 2019-12-16 |
| 2018-03-31 | $114.43M 10-K · filed 2019-01-25 |
| 2017-03-31 | $163.48M 10-K · filed 2017-12-11 |
| 2016-03-31 | $163.48M 10-K · filed 2016-12-14 |
| 2015-03-31 | $12.50M 10-K · filed 2015-12-29 |
| 2014-03-31 | $14.87M 10-K · filed 2014-12-29 |
| 2013-03-29 | $16.46M 10-K · filed 2013-12-30 |
| 2012-03-30 | $25.21M 10-K · filed 2012-12-31 |
| 2011-03-31 | $64.32M 10-K · filed 2011-12-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |